Vista Investment Partners’s Gilead Sciences GILD Stock Holding History

Vista Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$278K	Sell	2,200 -6	-0.3%	-$791	0.07%	148
2026 Q1	$307K	Sell	2,206 -71	-3%	-$9.94K	0.08%	139
2025 Q4	$279K	Buy	2,277 +119	+6%	+$14.5K	0.07%	143
2025 Q3	$240K	Buy	2,158 +35	+2%	+$3.98K	0.07%	146
2025 Q2	$235K	Buy	2,123 +5	+0.2%	+$532	0.07%	143
2025 Q1	$237K	Buy	+2,118	New	+$219K	0.07%	143

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Vista Investment Partners's GILD Position: Q2 2026 in Review

Vista Investment Partners reduced its Gilead Sciences (GILD) stake by 0.27% in Q2 2026, selling an estimated $791 and leaving 2,200 shares worth $278K. The position accounts for 0.07% of the portfolio, ranked #148.

Vista Investment Partners first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $307K in Q1 2026. 998 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Vista Investment Partners held 2,200 shares of Gilead Sciences worth $278K as of Q2 2026.
Vista Investment Partners sold 6 Gilead Sciences shares in Q2 2026, an estimated $791.
Gilead Sciences made up 0.07% of Vista Investment Partners's portfolio in Q2 2026, its #148 holding.
Vista Investment Partners first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
Vista Investment Partners's Gilead Sciences position peaked at $307K in Q1 2026.
998 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Vista Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.